GSK Plc is in discussions to purchase cancer treatment maker Nuvalent Inc. for between $9 billion and $10 billion, the Financial Times reported, citing unidentified people familiar with the matter.
GSK Plc is in discussions to purchase cancer treatment maker Nuvalent Inc. for between $9 billion and $10 billion, the Financial Times reported, citing unidentified people familiar with the matter.
SpaceX aims to sell 555.6 million shares at $135 apiece for its record-breaking $75 billion initial public offering, Reuters reported, citing an unidentified person familiar with the matter.
SpaceX aims to sell 555.6 million shares at $135 apiece for its record-breaking $75 billion initial public offering, Reuters reported, citing an unidentified person familiar with the matter.
Login
